Catalent | CTLT - Market Capitalization


Catalent reported $11.48B in Market Capitalization this December of 2024, considering the latest stock price and the number of outstanding shares.



Market Capitalization Change Date
Agilent USD 32.66B 5.2B Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Bruker USD 5.5B 1.66B Mar/2026
Centene USD 16.17B 4.06B Mar/2026
Charles River Laboratories USD 7.85B 2.17B Mar/2026
Cigna USD 70.33B 3.19B Mar/2026
Danaher USD 128.46B 33.24B Mar/2026
Dentsply International USD 2.32B 36M Mar/2026
Elevance Health USD 64.31B 13.6B Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Humana USD 20.82B 9.99B Mar/2026
Illumina USD 17.88B 2.74B Mar/2026
Intuitive Surgical USD 163.73B 37.04B Mar/2026
IQVIA Holdings USD 28.63B 9.76B Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Laboratory Of America USD 21.93B 1.13B Mar/2026
Lonza CHF 39.68B 980.61M Jun/2025
McKesson USD 106B 4.75B Mar/2026
Merck EUR 46.78B 6.52B Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Mettler Toledo International USD 25.54B 2.94B Mar/2026
Novartis USD 307.76B 15.54B Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
Quest Diagnostics USD 21.69B 2.39B Mar/2026
Repligen USD 6.64B 2.58B Mar/2026
Revvity USD 9.94B 1.03B Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Supernus Pharmaceuticals USD 2.98B 126M Mar/2026
Thermo Fisher Scientific USD 182.66B 35.04B Mar/2026
UnitedHealth USD 245.61B 53.42B Mar/2026
Veradigm USD 525M 621M Mar/2026
Waters USD 29.87B 7.25B Mar/2026
West Pharmaceutical Services USD 18.07B 1.73B Mar/2026